What Bactolife does

Bactolife A/S is a Danish biotechnology company founded in 2017 and headquartered in Copenhagen, developing proprietary Binding Proteins™ — milk-inspired proteins derived from natural camelid immunoglobulins and manufactured via scalable precision fermentation. The proteins selectively bind and neutralize undesired microbes and their metabolites in the gastrointestinal tract without disrupting the beneficial microbiome, offering a mechanism distinct from probiotics, prebiotics, or antibiotics. The technology is validated in animal models (6,000+ piglets tested) and is being translated into multiple target segments including mothers and children (with primary focus on infant formula applications), elderly gut health, immunodeficient individuals, travelers/deployed personnel, and animal feed (notably a zinc-oxide alternative for piglets).

The company operates as a B2B ingredient supplier, selling Binding Protein ingredients to food, beverage, dietary supplement, and animal feed manufacturers. Its human health ingredient brand, Helm™, is scheduled for first US launch in 2026, with EU and Asia expansion to follow; APAC entry is anchored by a strategic partnership with Korean probiotic leader AceBiome for combination products. Revenue streams span one-time/licensing sales of food and feed ingredients, with future licensing/royalty potential under the Helm brand. The company is venture-backed (over EUR 67 million raised across seed, Series A, Series B, and Gates Foundation grants), with no commercial revenue disclosed as of the input data, positioning it as a pre-commercial bioindustrial scale-up.

Name

Bactolife

Legal name

Bactolife A/S

Website

https://bactolife.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Bactolife is a Danish biotech that develops Binding Proteins™, milk-inspired ingredients produced via precision fermentation that selectively bind harmful gut metabolites, selling them as B2B ingredients to food, supplement, and feed manufacturers.

Ownership category

akta.pro rank

Product category

Gut Health Biotech Ingredients

NAICS

Animal Food Manufacturing (3111)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Specialized Dairy Nutrition Base Powder & Premix Manufacturing (Vitamin/Mineral/Functional Premixes) (AFAHAHAJ)

Keywords

• Gut health ingredients
• Binding proteins
• Functional food ingredients
• Animal feed additives
• Precision fermentation

Headquarters

HQ city

Lyngby

HQ country

Denmark

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Food Ingredient Sales: Bactolife develops and sells Binding Protein ingredients to food, beverage, and dietary supplement manufacturers. These ingredients are incorporated into functional foods, infant formula, dietary supplements, and other consumer health products.
2. Feed Ingredient Sales: Binding Proteins are sold as specialty feed ingredients for animal health applications, supporting gut balance in production animals such as piglets.
3. Ingredient Licensing (Helm Brand): Products launched under the Helm ingredient brand for human health applications, targeting dietary supplements, functional food and beverages. First human health product launch planned for US in 2026.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Bactolife develops and manufactures proprietary Binding Proteins — milk-inspired proteins derived from natural camelid immunoglobulins that selectively bind and neutralize harmful microbes and their metabolites in the gastrointestinal tract without disrupting beneficial microbiome components. These proteins are produced via scalable precision fermentation and sold as functional ingredients to food, beverage, dietary supplement, and animal feed manufacturers under the Helm™ brand for human health applications and as dedicated animal health feed additives.

Product overview

Bactolife is a Danish biotech company offering Binding Proteins™ as its core technology platform—a portfolio of milk-inspired, precision-engineered proteins produced via scalable microbial fermentation. The main product line is branded as Helm™ Binding Proteins for human health applications, including dietary supplements, functional foods, and beverages. The company also provides animal health feed additives. Products are segmented by consumer groups: mothers & children, elderly, immunodeficient individuals, travelers & deployed personnel, and production animals. The technology selectively binds and neutralizes undesired metabolites while preserving beneficial microbiome components.

Differentiator

Problem solved

Functional benefit

Brands

• Helm: Ingredient brand for Binding Proteins, used for human health applications. Launch planned for US market in 2026.

Products and services

• Binding Proteins™ Proprietary milk-inspired proteins derived from natural camelid immunoglobulins that selectively bind and neutralize undesired microbes and their metabolites in the gastrointestinal tract without disrupting beneficial microbiome components. Produced through precision fermentation using a scalable microbial manufacturing platform and sold as functional ingredients to food, beverage, dietary supplement, and animal feed manufacturers for incorporation into infant formula, functional foods, dietary supplements, beverages, and specialty feed formulations.
• Helm™ Binding Proteins The branded ingredient line for Bactolife's human health applications, providing animal-free and vegan-friendly Binding Protein ingredients for dietary supplements, functional foods, and beverages. First commercial launch planned for the US market in 2026 with subsequent expansion into EU and Asia.
• Animal Health Feed Additives Binding Protein feed additives for production animals, particularly piglets, providing a sustainable alternative to supplemental zinc oxide for managing post-weaning dysbiosis and supporting gut balance, animal welfare, and economic viability of farming operations. Validated efficacy demonstrated in more than 6,000 piglets.

Quantifiable outcome

• Demonstrated efficacy in 6,000+ piglets for animal health applications
• +1 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core and major.

• AceBiomecoreStrategic or Co-development Partner · 26 January 2026Korean microbiome and probiotic company, market leader in probiotics within Korea. Strategic partnership to launch the first probiotic-Binding Protein combination product in Korea, combining Helm Binding Proteins with AceBiome's probiotic strains. APAC expansion partner with focus on Southeast Asia.
• Technical University of Denmark (DTU)majorStrategic or Co-development PartnerAcademic research partner. Professor Lone Gram from DTU serves on Bactolife's Scientific Advisory Board. Collaborates on gut microbiome research and Binding Protein development.
• University of GothenburgmajorStrategic or Co-development PartnerAcademic research partner. Professor Fredrik Bäckhed from University of Gothenburg serves on Bactolife's Scientific Advisory Board, bringing expertise in molecular and clinical medicine.
• SEGES Danish Pig Research CentermajorStrategic or Co-development PartnerIndustry research partner collaborating on alternative solutions to zinc oxide in pig farming. Part of project supported by Danish Ministry of Environment and Food (GUDP program).
• Aarhus UniversitymajorStrategic or Co-development PartnerAcademic partner in collaborative project to develop alternatives to zinc oxide for pig farming. Working with Bactolife, DTU, and SEGES on sustainable animal health solutions.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Novonesis: Novonesis was formed through the merger of Novozymes and Chr. Hansen in 2024 and is the global leader in precision fermentation for food, beverage, and animal nutrition ingredients — including probiotics, cultures, enzymes, and bioactive proteins. It is the most direct incumbent comparable to Bactolife, with overlapping precision-fermentation technology, food/feed customer base, and gut-health category positioning. Bactolife's CEO and COO both come from Novozymes.
• Cargill: Global food and animal nutrition company with a large postbiotics and gut-health ingredients business (formerly through the Diamond V and postbiotic acquisitions). Overlaps with Bactolife in B2B functional ingredient sales to food, beverage, dietary supplement, and animal feed manufacturers. Bactolife's SVP US Liz Spence was previously Commercial Director and GM of Cargill's postbiotic business.
• ADM (Archer Daniels Midland): Global nutrition and agricultural processor with a large-scale human and animal nutrition ingredients business, including flavors, probiotics, and functional ingredients produced via fermentation. Comparable to Bactolife in B2B food and feed ingredient supply, with significantly larger scale and customer reach.
• Kerry Group: Irish-headquartered global taste and nutrition company selling ingredients (probiotics, postbiotics, enzymes, bioactive proteins) to food, beverage, and supplement manufacturers. Comparable to Bactolife in B2B functional ingredient sales, with adjacent gut-health technology (including GanedenBC30 probiotics) and broader portfolio diversification.
• IFF (International Flavors & Fragrances): Global ingredients company with a Health & Biosciences division producing cultures, probiotics, enzymes, and food ingredients via microbial fermentation (via the Danisco acquisition). Comparable to Bactolife in precision-fermentation-derived functional ingredients, with greater scale and broader category coverage.

Direct peers

• BioGaia: Swedish probiotics specialist developing Lactobacillus and Bifidobacterium strains for gut health, sold as dietary supplements and as functional food/infant formula ingredients globally. Direct peer to Bactolife in the gut-health ingredient category, though BioGaia's mechanism (probiotics) differs from Binding Proteins; both target infant formula, supplements, and clinical nutrition.

Emerging players

• Perfect Day: US-based precision fermentation company producing animal-free whey and casein proteins for food and nutrition applications using a similar fermentation platform to Bactolife's. Comparable as a fellow precision-fermentation functional protein company targeting B2B food and nutrition customers, though Perfect Day focuses on dairy-analogue proteins rather than gut-health binding proteins.
• The EVERY Company: US-based precision fermentation company (formerly Clara Foods) producing animal-free egg proteins and other functional proteins via microbial fermentation. Comparable to Bactolife in precision-fermentation-derived functional proteins targeting food and supplement applications, with a similar B2B ingredient business model.
• Vivici: Dutch B2B ingredients startup producing precision-fermentation dairy proteins (whey, casein) for food, beverage, and nutrition applications. Comparable to Bactolife as a fellow emerging precision-fermentation protein company targeting the B2B functional food ingredient market, with similar technology platform and growth stage.

Regional players

• Lallemand: Canadian-headquartered global producer of yeast, bacteria, and fermentation-derived ingredients for food, beverage, animal nutrition, and human health applications. Comparable to Bactolife in fermentation-derived functional ingredients and in animal feed (probiotics) for swine — a directly overlapping customer base in piglet gut health.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/bactolife

Revenue estimate

Valuation estimate

Number of profiles

Profiles23 records

Funding overview

Funding rounds4 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bactolife